<?xml version="1.0" encoding="UTF-8"?>
<p id="Par29">HBV reactivation was defined according to the AASLD guidelines as a ≥ 2 log increase in baseline HBV DNA in HBsAg-positive patients, or reappearance of HBsAg or detectable HBV DNA in patients who had been previously HBsAg-negative/anti-HBc-positive (reverse seroconversion)
 <sup>
  <xref ref-type="bibr" rid="CR28">28</xref>
 </sup>.
</p>
